Search filters

List of works by M A O'Donnell

A novel expression of macrophage derived chemokine in human bladder cancer

scientific article published on 01 March 2005

An in vivo comparison of bacillus Calmette-Guérin (BCG) and cytokine-secreting BCG vaccines

scientific article published on 01 April 1999

Animal Models of Urologic Chronic Pelvic Pain Syndromes: Findings From the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network

scientific article published on June 2015

Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.

scientific article

Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette--Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity.

scientific article published on July 2014

Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper?

scientific article published on 01 September 2004

BCG immunotherapy of bladder cancer: 20 years on.

scientific article

BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation

scientific article published on 01 June 2000

Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

scientific article published on 01 September 2003

Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer.

scientific article published on 29 December 2016

Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease

scientific article

Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro

scientific article published on 01 June 1996

Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.

scientific article published on 17 September 2010

Bladder Cancer Immunotherapy: BCG and Beyond.

scientific article

Bladder cancer: narrowing the gap between evidence and practice

scientific article

Can a point-of-care urine protein assay monitor bladder cancer recurrence?

scientific article published on 01 September 2006

Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant

scientific article published on 01 March 2000

Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop.

scientific article published on 12 December 2013

Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer

scientific article published on 14 July 2018

Combination of BCG and interferon intravesical immunotherapy: an update.

scientific article published on 29 May 2009

Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis.

scientific article published in December 2003

Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study

scientific article published on 15 May 2019

Does ofloxacin protect against BCG-related toxic effects in patients with bladder cancer?

scientific article published on 10 April 2007

Does the interval between prostate biopsy and radical prostatectomy affect the immediate postoperative outcome?

scientific article

Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?

scientific article published on 26 August 2008

Dose-dependent synergy of Th1-stimulating cytokines on bacille Calmette-Guérin-induced interferon-gamma production by human mononuclear cells

scientific article published on 21 May 2007

Entrez into the immunogenetics of superficial bladder cancer response to bacillus Calmette-Guerin

scientific article published on 01 April 2006

Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy

scientific article published on 28 May 2015

Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.

scientific article

Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

scientific article

Factors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situ

scientific article published on 23 July 2011

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer

scientific article published on 01 July 2006

Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy

scientific article published on 01 February 2008

Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs

scientific article published on 01 December 2007

Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival

scientific article published on 23 June 2016

Inflammation and Symptom Change in Interstitial Cystitis or Bladder Pain Syndrome: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Study.

scientific article published on 05 January 2016

Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms.

scientific article

Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer.

scientific article published on 28 April 2013

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

scientific article published on 01 September 2004

Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity.

scientific article

Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity

scientific article published on 01 March 2004

Interleukin-12. Opportunities for the treatment of bladder cancer.

scientific article

Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts

scientific article published on 11 February 2015

Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.

scientific article

Intravesical colonic pseudotumor

scientific article published on 01 January 2004

Intravesical treatments of bladder cancer: review.

scientific article published on 28 March 2008

Intravesicular taxane-induced dermatotoxicity in a 78-year-old man with urothelial carcinoma and primary cutaneous anaplastic large cell lymphoma.

scientific article

Management of stage T1 tumors of the bladder: International Consensus Panel.

scientific article

Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin

scientific article published on 01 June 2002

Minimally invasive management of upper tract urothelial carcinoma.

scientific article

Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo

scientific article published on 01 February 2007

New imaging techniques for non-muscle invasive bladder cancer: ready for primetime

scientific article published on 07 March 2013

Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer

scientific article published on 27 July 2017

Optimizing BCG therapy

scientific article published on 01 May 2009

Patient-recognition data-mining model for BCG-plus interferon immunotherapy bladder cancer treatment.

scientific article

Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study

scientific article published on 11 August 2018

Pharmacological biocompatibility between intravesical preparations of BCG and interferon-alpha 2B

scientific article published on December 1, 1997

Phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder

scientific article published on 01 July 2003

Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer.

scientific article

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.

scientific article

Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis

scientific article published on March 1, 1998

Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.

scientific article published on 8 August 2017

Recognition and treatment of BCG failure in bladder cancer.

scientific article published on 7 March 2011

Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

scientific article published on July 2004

Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity

scientific article published on 01 February 2001

Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins.

scientific article

Reply by the authors

Review of topical treatment of upper tract urothelial carcinoma.

scientific article published on 5 November 2008

Risk-adapted use of intravesical immunotherapy.

scientific article

Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer

scientific article published on 04 July 2012

Rubin H. Flocks and colloidal gold treatments for prostate cancer.

scientific article published on 16 August 2011

Safety and efficacy of intravesical bacillus Calmette-Guérin plus interferon α-2b therapy for nonmuscle invasive bladder cancer in patients with prosthetic devices.

scientific article published on 17 September 2010

Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist

scientific article published on January 1, 2011

Sub-noxious Intravesical Lipopolysaccharide Triggers Bladder Inflammation and Symptom Onset in A Transgenic Autoimmune Cystitis Model: A MAPP Network Animal Study.

scientific article

Superficial bladder cancer: the role of interferon-alpha.

scientific article published in June 1998

Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer

scientific article published on 01 July 2018

Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.

scientific article

The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.

scientific article published on March 2004

The genetic reconstruction of BCG as a new immunotherapeutic tool.

scientific article published on December 1997

The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy

scientific article published on 01 May 2006

The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.

scientific article

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer

scientific article published on 06 October 2008

Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study

scientific article

Transgenic Mice Expressing MCP-1 by the Urothelium Demonstrate Bladder Hypersensitivity, Pelvic Pain and Voiding Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study

scientific article

Transitional cell carcinoma--tantalizing issues of tumor biology

scientific article published on 01 September 1996

Treatment of Postoperative Ileus After Bowel Surgery with Low-Dose Intravenous Erythromycin

scientific article published on 01 April 2007

Treatment options for BCG failures.

scientific article published on November 2006

Treatment options in non-muscle-invasive bladder cancer after BCG failure

scientific article

Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

scientific article published in May 2004

Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs.

scientific article published in March 2005

Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model.

scientific article published in December 2004

Usefulness of the Spanish Urological Club for Oncological Treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Guérin plus interferon-α.

scientific article published on 12 November 2010

When medical evidence alone is simply not enough

scientific article published on 01 June 2009